Meeting Coverage >

AHA

Diuretics on Par in Head-to-Head Comparison for Hypertension

But a surprise signal emerges for one group in pragmatic trial

Mixed Results With Pemafibrate in Patients With Type 2 Diabetes

No impact on CV events in PROMINENT; developer brings trial to an end

Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalization

Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study

Bentracimab on Point as Fast-Acting Ticagrelor Reversal Agent

"Immediate and sustained" benefit, interim REVERSE-IT analysis found

Oral Factor XIa Inhibitor Sets the Stage for a Safer Anticoagulant

Milvexian shows promise in preventing vein clots after total knee replacement surgery

Oral PCSK9 Inhibitor Slashed Cholesterol

Reductions of 65% observed in phase I trials

Potent Antiplatelet Not a Good Idea for Moderate COVID-19

ACTIV-4a trial suggests harm for hospitalized patients outside the ICU

Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin

EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says

Vascepa Succumbs as COVID Treatment in 'Underpowered' Trial

Purified fish oil didn't help SARS-CoV-2-positive outpatients

Aspirin Flops Again for Dementia Prevention

ASCEND trial sides with ASPREE, but can't rule out some potential benefit

Stem Cells Don't Prevent Acute Heart Failure Events

DREAM-HF trial does hold some positive signals, though

Some Good News for Curious Afib Patients Looking to Find Their Own Triggers

Presumed Afib triggers put to the test in n-of-1 studies

PALACS: A Win for Posterior Left Pericardiotomy for Post-Op Afib

Trial offers good news for patients getting coronary, aortic valve, and aortic surgeries

Two Anticoagulants -- When Used Correctly -- Similarly Protective Against Dementia

GIRAF trial tested warfarin versus dabigatran in older Afib patients

Coffee Causes This One Arrhythmia, Trial Shows

Overall mixed results in the CRAVE randomized trial

Tricuspid Repair Boosts Mitral Valve Surgery Outcomes

Randomized trial supports combined surgery for moderate regurgitation

Delaying Surgery Hurts Patients With Silent Aortic Stenosis

Early aortic valve replacement wins in AVATAR trial

Early CABG After Stopping Ticagrelor is Possible -- But is It Ready for Prime-Time?

RAPID CABG shows non-inferority of shorter wait; expert advises caution for real-world practice

Antibiotics Slow Down Latent Rheumatic Heart Disease in Kids

GOAL trial supports screening

VITAL-AF, mSToPS: Mixed Results in Afib Screening

A signal that screening by continuous ECG monitoring leads to better outcomes

After Stenting, Aspirin May Be Just as Good Solo After 1-Month DAPT

Randomized trial makes a case for dropping the P2Y12 inhibitor

Omega-3s Humbled by Corn Oil Placebo in Two Trials

Implications for REDUCE-IT's icosapent ethyl unclear

SAMSON Trial: 90% of Statin Complaints Are Nocebo Effect

Placebo challenge had positive results for many patients, though

Xarelto Works for Prevention in Valvular Afib

RIVER trial may open the door to use in broader populations

43% Cardiac Arrest Survival? ECMO Strategy Promising in Early Studies

Exceeded expectations for outcomes

Omecamtiv's Benefit in HFrEF Trial Gets Lukewarm Reception

Can novel oral drug stand out from the crowd?

Oversupply of Congenital Heart Surgery Programs Slammed

Researchers call for fewer hospitals in an organized, regionalized system

Impella More Expensive, More Dangerous?

Observational study also shows increasing use

Entresto Data Support Wider Reach of 'Fifth Pillar' HF Drug

Benefits observed beyond HF patients with reduced EF

Xarelto Harm for TAVR Patients Still Unexplained

GALILEO showed worse outcomes but less subclinical leaflet thrombosis

HF Benefit of Dapagliflozin Affirmed in Non-Diabetics

Fewer CV events for heart failure with reduced ejection fraction

Vaping Worse for Heart Than Cigarettes?

It's not just lung injury e-cigarette users should worry about, study says

AHA: Neighborhood Violence Takes Toll on Heart

Studies connect steady diet of violence to early heart disease

AHA: Stem Cells No Help in LVAD Patients

Mesenchymal precursor cells didn't boost wean rates from heart assist devices

AHA: Closing Dialysis Fistula Improves Heart Function

Kidney transplant patients may benefit from reversing arteriovenous connection

AHA: CABG Still Better for Multivessel Disease in Diabetes

FREEDOM trial extension suggests lower long-term mortality vs stents

National Exercise Guidelines Now Say 'Just Move'

HHS recs say to sit less, move more to improve health outcomes

AHA: Rivaroxaban May Cut Thromboembolic Risk in HF Patients

Post hoc analysis of COMMANDER HF trial suggestive of benefit

AHA: DCM Recovery Often Doesn't Mean Cure

Stopping meds led to relapse of dilated cardiomyopathy for many in TRED-HF trial

AHA: In-hospital Entresto Safe, Beneficial in HFrEF

PIONEER-HF shows improved biomarkers and possibly outcomes too

1